about
Poor sensitization of 50-kHz vocalization response to amphetamine predicts rat susceptibility to self-administration of the drug.Serotonin and depression: old problems and new data.The effects of repeated administration of diazepam, MK-801 and CGP 37849 on rat behavior in two models of anxiety.Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats.The behavioral effects of NMDA antagonists in serotonin depleted rats.The effects of group III mGluR ligands on pentylenetetrazol-induced kindling of seizures and hippocampal amino acids concentration.GABAergic control of the activity of the central nucleus of the amygdala in low- and high-anxiety rats.The effects of antidepressants and electroconvulsive shocks on the functioning of the mesolimbic dopaminergic system: a behavioral study.N-acetyl cysteine does not modify the sensitization of the rewarding effect of amphetamine as assessed with frequency-modulated 50-kHz vocalization in the rat.Midazolam treatment before re-exposure to contextual fear reduces freezing behavior and amygdala activity differentially in high- and low-anxiety rats.The effects of acute and chronic administration of corticosterone on rat behavior in two models of fear responses, plasma corticosterone concentration, and c-Fos expression in the brain structures.The effects of central administration of physostigmine in two models of anxiety.The role of the hippocampus and 5-HT/GABA interaction in the central effects of benzodiazepine receptor ligands.Fluoxetine attenuates the effects of pentylenetetrazol on rat freezing behavior and c-Fos expression in the dorsomedial periaqueductal gray.The effect of chronic administration of corticosterone on anxiety- and depression-like behavior and the expression of GABA-A receptor alpha-2 subunits in brain structures of low- and high-anxiety rats.Effects of buspirone, diazepam, and zolpidem on open field behavior, and brain [3H]muscimol binding after buspirone pretreatment.GABAergic mechanisms in the nucleus accumbens septi regulating rat motor activity: the effect of chronic treatment with desipramine.The role of brain serotonin in the electroconvulsive shock-induced changes in behavioural effects of intra-hippocampally injected clonidine.Neophobia and cortical and subcortical binding of the dopamine D2 receptor antagonist [3H]-raclopride.Behavioral, biochemical and histological studies in a model of pilocarpine-induced spontaneous recurrent seizures.Midazolam inhibits neophobia-induced Fos expression in the rat hippocampus.The localization of brain sites of anxiogenic-like effects of urocortin-2.Serotonergic innervation of the hippocampus and nucleus accumbens septi and the anxiolytic-like action of the 5-HT3 receptor antagonists.Effects of morphine and methadone treatment on mRNA expression of Gα(i) subunits in rat brains.The effects of midazolam and D-cycloserine on the release of glutamate and GABA in the basolateral amygdala of low and high anxiety rats during extinction trial of a conditioned fear test.The influence of the long-term administration of Curcuma longa extract on learning and spatial memory as well as the concentration of brain neurotransmitters and level of plasma corticosterone in aged rats.The influence of CRF and alpha-helical CRF(9-41) on rat fear responses, c-Fos and CRF expression, and concentration of amino acids in brain structures.Antagonism of picrotoxin-induced changes in dopamine and serotonin metabolism by allopregnanolone and midazolam.The role of the dorsomedial part of the prefrontal cortex serotonergic innervation in rat responses to the aversively conditioned context: behavioral, biochemical and immunocytochemical studies.Chronic treatment with antidepressant drugs and ECT differentially modifies the hypothermic action of clonidine and guanfacine.Effects of pentylenetetrazol-induced kindling of seizures on rat emotional behavior and brain monoaminergic systems.Changes in the brain expression of alpha-2 subunits of the GABA-A receptor after chronic restraint stress in low- and high-anxiety rats.Rat behavior in two models of anxiety and brain [3H]muscimol binding: pharmacological, correlation, and multifactor analysis.The effect of fluoxetine in a model of chemically induced seizures--behavioral and immunocytochemical study.Corticosterone modulates fear responses and the expression of glucocorticoid receptors in the brain of high-anxiety rats.The effect of CRF and alpha-helical CRF((9-41)) on rat fear responses and amino acids release in the central nucleus of the amygdala.Extended blockade of the discriminative stimulus effects of nicotine with low doses of ethanol.Buspirone attenuates conditioned fear-induced c-Fos expression in the rat hippocampus.Expression of c-Fos and CRF in the brains of rats differing in the strength of a fear response.Altered expression of GABA-A receptor subunits in the hippocampus of PTZ-kindled rats.
P50
Q27324591-59B14436-071D-4FD5-9088-06BDE06CCAF4Q31036193-541D9E0A-9A39-44ED-AAFE-CD7C8A16B700Q34402474-500DE181-6B3B-4A14-B369-33F81B679578Q34416576-70F2C97A-19F2-44BF-844C-0019A5E80644Q34742634-B558F619-870E-4BDA-9830-6C04AAD3F859Q34983905-6A6CB49C-5DFE-4FE3-BFA8-A795AC60559BQ40595877-C03A6351-98E4-4925-A021-DDC967699BAEQ41456948-2959DF97-A4FB-48CB-A70A-9464D0040EDFQ41702938-11263F19-645C-4D45-8CC5-3E6DC93845C8Q41720208-B7CEF3BF-B64C-4E57-8B98-4452A531A9D2Q42603589-A43896BF-3451-4D47-9790-8821D4308AAEQ42604027-349501E9-0131-4CE1-8230-4E97401A1431Q42607638-BAC66FD9-050E-4DB4-9354-2CF706EA3410Q42608268-D5672E2D-3E10-40A7-83C7-DE534722BC64Q42626810-D3B642D7-207C-4381-9735-565A16287A36Q42629966-E9261D0F-CB4A-448D-A60C-871F93528BE8Q42632034-ADBFC2A1-814A-4263-B1C7-ADD6713643DDQ42641847-49E5E80E-3642-45AA-ACF1-40E1DFBF4408Q42642017-0413EF99-8124-46DF-A975-C91AFE039B73Q42656468-075280D9-5957-4553-9B76-F83FAB278B2EQ42676399-2A4AAF05-D6D7-4E1E-BAED-8AE69C61BFAEQ42683650-490C4277-6ACE-4DA7-834A-F59CFCF03DFFQ42692565-D53CB2A3-2CDD-4B4F-BE09-E42E55E6AC7FQ42754352-D2BD4B85-55CD-4A7A-AD54-85717899D087Q42921123-99F3716A-185C-4E98-B0F8-EB7D9036F2A6Q43135010-6D181F06-D987-447A-AF31-48EAB8598FE8Q43498132-EBF05C38-47E6-4F39-8456-9DA8F9632870Q44026280-381C6D01-12FD-48D8-AA5F-538F5A2EF981Q44083281-6046D87A-9880-4124-B808-D27630F39A4DQ44091969-D36611B4-3FCB-4ACE-B4F4-A17EB7C45D32Q44126678-8EC7EC16-75F0-4ED0-A4E7-B5538E3A8D31Q44131173-04E1EF0A-2E4C-4DFF-91A0-579254BE28F1Q44608546-374FB2D4-ED1D-4D8E-8AB4-715AB0122C87Q45201860-C5214FCF-A294-40A0-B522-3E554C5273ECQ45842039-76EAC122-44BF-493D-8676-631035DF8F1CQ45992330-F866EAB8-9A9A-49C4-9E79-A6554E67223CQ46445619-CBCA8F29-22EB-4EFD-859B-4F956DA0F892Q46646373-3B8F5EF3-18B5-40D3-A983-142108789007Q46859431-1383E60F-CAEC-401E-95CD-FEA54A7EF666Q47201877-D2897045-B171-4AFB-9B71-2B25BD21F9E8
P50
description
researcher ORCID ID = 0000-0002-4263-9836
@en
wetenschapper
@nl
name
Adam Plaznik
@ast
Adam Plaznik
@en
Adam Plaznik
@es
Adam Plaznik
@nl
Adam Płaźnik
@pl
type
label
Adam Plaznik
@ast
Adam Plaznik
@en
Adam Plaznik
@es
Adam Plaznik
@nl
Adam Płaźnik
@pl
altLabel
Adam Eugeniusz Płaźnik
@pl
Adam Płaźnik
@en
prefLabel
Adam Plaznik
@ast
Adam Plaznik
@en
Adam Plaznik
@es
Adam Plaznik
@nl
Adam Płaźnik
@pl
P106
P1153
7005154607
P1559
Adam Płaźnik
@pl
P21
P31
P3124
P496
0000-0002-4263-9836